accutane zeno

Researchers at the Quadram Institute on the Norwich Research Park have shown how the development of antibiotic resistance by bacteria can have ‘side-effects’ for them including affecting their ability to cause disease. Antibiotic resistance remains one of the greatest challenges to global health with very few new antibiotics and widespread resistance. It has been estimated […]

CYCN Awaits Sickle Cell Disease Data, TTPH Finalizes Its Suitor, ADMS Faces FDA In Feb

Today’s Daily Dose brings you news about Adamas Pharma’s date with the FDA; Cyclerion’s near-term catalysts; the pipeline progress of Mereo; FDA approval of Merck’s combination antibiotic Recarbrio for a new indication; and the bidding war for Tetraphase. Read on… 1. Adamas To Face FDA On Feb.1, 2021 Adamas Pharmaceuticals Inc.’s (ADMS) supplemental New Drug […]

Stock To Watch: Will Second Time Be A Charm For ScPharma (SCPH)?

scPharmaceuticals Inc. (SCPH), which closed at a new 52-week high of $8.64 in the last trading session of Feb.14, has two late-stage programs with significant market potential. scPharmaceuticals is a clinical-stage pharmaceutical company developing products that have the potential to optimize the delivery of infused therapies and reduce health-care costs. The Company’s lead drug candidates […]